News Breaks |
|
|
| January 31, 2013 |
| 12:02 EDT |  | UTHR, ENDP, TSM, WMS, LBTYA | High option volume stocks: ENDP LBTYA TSM UTHR WMS
|
|
|
News For ENDP;LBTYA;TSM;UTHR;WMS From The Last 14 Days Check below for free stories on ENDP;LBTYA;TSM;UTHR;WMS the last two weeks. |
|
|
| June 18, 2013 |
| 07:12 EDT |  | LBTYA | Liberty Global enters talks with Kabel Deutschland, WSJ reports
German cable operator Kabel Deutschland confirmed it received a proposal to be acquired by Liberty Global (LBTYA), potentially creating a bidding war with Vodafone (VOD), reports the Wall Street Journal.Reference Link |
|
| 06:01 EDT | | LBTYA | On the Fly: Periodicals Wrap-Up
 Subscribe for More Information |
|
| June 17, 2013 |
| 17:49 EDT |  | LBTYA | Liberty Global files prospectus for 14.39M class A shares
Subscribe for More Information |
|
| 15:02 EDT |  | LBTYA | Liberty Global down 2% after report of bid for Kabel Deutschland
Subscribe for More Information |
|
| 14:43 EDT | | LBTYA | Liberty Global competing with Vodafone for Kabel Deutschland, FT says
Liberty Global (LBTYA) is bidding against Vodafone (VOD) for Kabel Deutschland and has tabled a potential offer that values the cable operator at about EUR7.5B, according to Financial Times, citing people familiar with the talks. Reference Link |
|
| June 13, 2013 |
| 10:28 EDT | | ENDP | Brahman Capital reports 5.65% passive stake in Endo Health
|
|
| 07:33 EDT | | LBTYA | A Vodafone bid for Kabel Deutscland might run into Liberty Global, Reuters says
Subscribe for More Information |
|
| 06:21 EDT | | TSM | TSMC CEO expects record earnings and sales in 2013, DigiTimes reports
TSMC CEO Morris Chang says the company is expected to post record earnings and sales in 2013 as 2H13 is expected to outperform 1H13, reports DigiTimes. Chang said although the industry outlook for Q4 is unclear, he sees "pretty good" industry conditions in Q3. Reference Link |
|
| June 12, 2013 |
| 05:10 EDT | | LBTYA | Liberty Global announces $3.5B share repurchase program
Subscribe for More Information |
|
| June 10, 2013 |
| 11:52 EDT | | LBTYA | Telefonica seeks bids for Irish unit during June, Bloomberg says
Telefonica (TEF) is said to be seeking offers for its Irish unit, 02, within this month, reported Bloomberg, citing two people with information on the matter. The sale process is being run by Bank of America (BAC) and Hutchison Whampoa, Eircom Group and Liberty Global’s (LBTYA) UPC Ireland were among those that received sale information, one source said. Reference Link |
| |
| June 7, 2013 |
| 11:05 EDT | | LBTYA | Liberty Global completes $24B stock and cash merger with Virgin Media
Subscribe for More Information |
|
| June 6, 2013 |
| 10:01 EDT |  | ENDP | On The Fly: Analyst Downgrade Summary
Subscribe for More Information |
|
| 10:01 EDT |  | ENDP | On The Fly: Analyst Upgrade Summary
Subscribe for More Information |
|
| 07:53 EDT | | ENDP | Endo Health upgraded to Outperform from Market Perform at Leerink
Subscribe for More Information |
|
| 07:22 EDT |  | ENDP | Endo Health restructuring slightly ahead of schedule, says Jefferies
Subscribe for More Information |
|
| 06:34 EDT | | ENDP | Endo Health downgraded to Sell from Hold at Cantor
Subscribe for More Information |
|
| June 5, 2013 |
| 17:45 EDT | | ENDP | Endo terminates sales and promotional pact with Ventiv
Subscribe for More Information |
|
| 16:30 EDT |  | ENDP | Endo Health revises FY13 adjusted EPS view to $4.10-$4.40, consensus $4.27
Revises FY13 revenue guidance to $2.65B-$2.8B, consensus $2.8B. The company's 2013 guidance is based on certain assumptions including adjusted gross margin of between 64%-66%; adjusted effective tax rate of between 27.5%-28.5%; adjusted operating expenses to be reduced by approximately $150M when compared with FY12; the company continues to expect a single generic competitor for Lidoderm in September. |
|
| 16:23 EDT | | ENDP | Endo Health to explore strategic alternatives for HealthTronics business
In keeping with its more disciplined capital allocation framework, the company is evaluating strategic alternatives for its HealthTronics business, which provides urological services, products and support systems to various healthcare providers in the U.S. Endo also announced plans to explore alternatives for its branded pharmaceutical early stage discovery platform, which is made up of several drug discovery candidates in multiple therapeutic areas. The company will continue to evaluate the performance of its remaining businesses so that their respective cash flows and returns are consistent with Endo's investment criteria. |
|
| 16:23 EDT | | ENDP | Endo Health, announces strategic alternatives, to reduce workforce by 15%
Subscribe for More Information |
| |
|
|
|
|
